Skip to main content
. Author manuscript; available in PMC: 2011 May 18.
Published in final edited form as: Neuroimage. 2008 May 20;42(2):559–567. doi: 10.1016/j.neuroimage.2008.05.012

Table 4.

Clinical diagnosis at the time of MRI scan and aSTAND-score based classification for all autopsy subjects by Braak NFT stage.

Braak NFT Stage
0–I (n=7) II (n=9) III (n=16) IV (n=11) V (n=31) VI (n=27)
Clinical Diagnosis at MRI
Normal 7 (100%) 8 (89%) 9 (56%) 5 (45%) 4 (13%) 0
aMCI 0 1 (11%) 4 (25%) 2 (18%) 5 (16%) 1 (4%)
AD 0 0 3 (19%) 4 (36%) 22 (71%) 26 (96%)
Diagnosis using MRI scan based aSTAND-score (aSTAND-score ≥ 0 for AD; <0 for CN)
Normal 7 (100%) 5 (56%) 11 (69%) 2 (18%) 4 (13%) 1(4%)
AD 0 4 (44%) 5 (31%) 9 (82%) 27 (87%) 26 (96%)

aMCI = amnestic mild cognitive impairment; AD = Alzheimer’s disease;

aSTAND-score = adjusted Structural Abnormality iNDex-score.

HHS Vulnerability Disclosure